Are we helping or harming our insulin-treated diabetic patients during ambulatory treatment?

Grzegorz Szcześniak 1, Piotr Dziemidok 2, Piotr S. Paprzycki 3
1 - Diabetology Ward, Institute of Rural Health, Lublin, Poland
2 - Diabetology Ward, Institute of Rural Health, Lublin, Poland; Institute of Public Health, Pope John Paul II State School of Higher Education, Biala Podlaska, Poland
3 - Department of Functional Research, Institute of Rural Health, Lublin, Poland
Ann Agric Environ Med
2013; 20 (2):
ICID: 1052344
Article type: Original article
 
 
Introduction. Correctness of insulin treatment depends on both the experience and skills of the doctor and knowledge and behaviour of the patient.
Objective. Evaluation the adequacy of insulin doses administered to diabetes patients in ambulatory conditions.
Material and methods. The treatment of 59 patients hospitalized in the Diabetology Ward was evaluated at admission, discharge and 3 months after hospitalization.
Results. The mean daily doses of insulin significantly differed at times of evaluation and were: 53.90, 39.31 and 43.34 units, respectively (p≈0.000001). A significant reduction of body weight, 90.86 vs. 88.25 kg (p≈0.000001), was obtained only during hospitalization, and was maintained 3 months after discharge (87.86 kg). Significant differences were also noted in the body mass index (33.44 vs. 32.48 vs. 32.37 kg/m2 , p≈0.000001). The change in waist circumference was not statistically significant (107.87 vs. 104.89 cm; p≈0.06). A decrease in the number of hypoglycaemia episodes was observed, but were statistically insignificant (25 vs. 23; p≈0.7). Three months after hospitalization an insignificant decrease of HbA1c level was noted (8.41% vs. 8.03%; p≈0.07).
Conclusions. During treatment in the Diabetology Ward the procedure of choice was more frequently a reduction than an increase in insulin doses. This management led to the reduction of the patients’ body weight, improvement of glycaemia, without any significant effect on the diabetes control determined by the HbA1c level.
PMID 23772589 - click here to show this article in PubMed
  FULL TEXT STATS

Recommend this article to:

Name:
E-mail:
From:
Language:


Related articles in IndexCopernicus™
     Glucosylated hemoglobin A [1 related records]
     body weight [5 related records]
     insulin therapy [1 related records]
     Diabetes mellitus [35 related records]



 

Related articles

M Baeis, S Mohebi,
Study of Metabolic Syndrome Based on the NCEP/ATP ...
Background and Objectives: Metabolic syndrome (MS) is a group of metabolic disorders, which its prevalence is growing worldwide and increases the risk of diabetes and cardiovascular diseases. In the present study, the metabolic syndrome status was in...
ABSTRACT
M Moradi, F Haghighatdoost,
EFFECT OF CO-Q10 SUPPLEMENTATION ON FASTING BLOOD ...
Background: Several studies have evaluated the effects of coenzyme Q10 on glycemic control, but there are large discrepancies between studies.Objective: This meta-analysis of randomized controlled trials aimed to summarize the effect of Co-Q10 on dia...
ABSTRACT
M Abdolbaghi, M Pourmand,
Prevalence and contributing factors of methicillin...
Background: Diabetic foot infections a common complication of diabetes. Staphylococcus aureus is most common pathogen associated with diabetic foot infection. Frequency of methicillin-resistant Staphylococcus aureus (MRSA) associated with diabetic fo...
ABSTRACT